Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$7.23M Buy
65,477
+3,074
+5% +$334K 0.07% 264
2014
Q4
$6.5M Sell
62,403
-2,287
-4% -$229K 0.07% 285
2014
Q3
$6.21M Sell
64,690
-12,381
-16% -$1.12M 0.09% 214
2014
Q2
$7.04M Buy
77,071
+4,031
+6% +$361K 0.1% 194
2014
Q1
$6.43M Buy
73,040
+2,394
+3% +$210K 0.09% 213
2013
Q4
$6.55M Buy
70,646
+3,163
+5% +$285K 0.11% 207
2013
Q3
$5.51M Buy
67,483
+8,031
+14% +$678K 0.1% 233
2013
Q2
$4.94M Buy
+59,452
New +$5.12M 0.1% 240

Other funds holding CLX

Baird's CLX Position: Q1 2015 in Review

Baird increased its Clorox (CLX) stake by 4.9% in Q1 2015, buying an estimated $334K and bringing the position to 65,477 shares worth $7.23M. The position accounts for 0.07% of the portfolio, ranked #264.

Baird first reported a position in CLX in Q2 2013 and has held it in 8 quarters since. 746 funds tracked by Wall St. Rank hold CLX as of Q1 2015.

  • Baird held 65,477 shares of Clorox worth $7.23M as of Q1 2015.
  • Baird bought 3,074 Clorox shares in Q1 2015, an estimated $334K.
  • Clorox made up 0.07% of Baird's portfolio in Q1 2015, its #264 holding.
  • Baird first reported a position in Clorox in Q2 2013 and has held it in 8 quarters since.
  • 746 funds tracked by Wall St. Rank held Clorox as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.